Speakers

Chris Gagliardi
David Gold
David Pajerowski
Donmienne Leung
Emma Smith

Chris Gagliardi

Principal

Sanofi Venture

David Gold

Vice President Business Development

Sonoma Biotherapeutics

David Pajerowski

Founding Chief Technology Officer

Flip Therapeutics

Donmienne Leung

Director AbbVie Ventures

AbbVie

Emma Smith

Head of Immune Reset

UCB

Frank Brennan
Jonathan Zombeck
Jordan Zwick
Julia Manasson
Julie Di Paolo

Frank Brennan

Head of Immunology Translation

UCB

Jonathan Zombeck

Director Business Development

Visterra, an Otsuka Company

Jordan Zwick

Chief Business Officer

Mirador Therapeutics

Julia Manasson

Medical Director

Seismic Therapeutic

Julie Di Paolo

Senior Director, Immunology Scientific Innovation Lead

Johnson & Johnson

1
Kalpana Gupta
Kevin White
Luke Henry
Max Zeiberg

Julien Genovino

Associate Director, Global Business Development & Strategy

Otsuka

Kalpana Gupta

Head of Immunology, Infectious Diseases & Metabolism Partnering

Regeneron

Kevin White

Head of Immune Tolerance  Therapeutics Discovery

AbbVie

Luke Henry

Chief Business Officer

Quell Therapeutics

Max Zeiberg

Vice President Business Development

Sana Biotechnology

Melissa Matzelle
Neel Desai
Nicola La Monica
paul andrews
saifur rahman

Melissa Matzelle

Director, Immunology Search & Evaluation

AbbVie

Neel Desai

Executive Director, Business Development

Biogen

Nicola La Monica

Senior Director, Strategic Search & Evaluation

Johnson & Johnson

Paul Andrews

Director, External Innovation

Biogen

Saifur Rahman

Director, Business Development & Licensing

Sanofi

5
3
Swarna Balasubramanian
Tatiana Ort
Albert Hsia - Merck - Autoimmunity Pharma & Biotech Partnering Summit 2024

Samik Basu

Chief Scientific Officer

Cabaletta

Sean Evans

Senior Associate Venture Investments

Johnson & Johnson

Swarna Balasubramanian

Associate Director, Search & Evaluation, Respiratory & Immunology

AstraZeneca

Tatiana Ort

Head of Bioscience Immunology

AstraZeneca

Albert Hsia

Executive Director, Business Development

Merck

Brian Freed - Rhumagen - Autoimmunity Pharma & Biotech Partnering Summit 2024

Brian Freed

Chief Scientific Officer

Rhuemagen